-

Enfusion to Present at Upcoming Investor Events

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of cloud-native investment management software and services, today announced that Enfusion’s Chief Executive Officer, Thomas Kim, and Chief Financial Officer, Steve Dorton, will participate at the following investor events:

  • William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022
  • Bank of America 2022 Global Technology Conference on Wednesday, June 8, 2022
  • Morgan Stanley US Financials, Payments & CRE Conference on Monday, June 13, 2022

About Enfusion

Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one cloud-native system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence, boosting agility, and powering growth. Enfusion partners with 730+ investment managers from ten global offices spanning five continents.

Source: Enfusion, Inc.
Source Code: ENFN-IR
ENFN-CORP

Contacts

Investors
Ignatius Njoku
investors@enfusion.com

Press
Prosek Partners
pro-enfusion@prosek.com

Industry:

Enfusion, Inc.

NYSE:ENFN
Release Versions
English

Contacts

Investors
Ignatius Njoku
investors@enfusion.com

Press
Prosek Partners
pro-enfusion@prosek.com

More News From Enfusion, Inc.

Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced that on January 9, 2023, its Board of Directors (the “Board”) had appointed Michael Spellacy, as Board Chair, effective immediately. “We are delighted with the addition of Michael Spellacy and are fortunate to have a leader with Mr. Spellacy’s strategic experience as our next Board chair. We l...

Enfusion Names Oleg Movchan as Chief Executive Officer

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, today announced that its Board of Directors (the “Board”) has appointed Oleg Movchan, as Chief Executive Officer, effective December 22, 2022. Mr. Movchan has been serving as Interim Chief Executive Officer since August 21, 2022. “We appreciate Oleg’s impact during his tenure as interim CEO and are fortunate to have a leader of Oleg...

Enfusion Appoints Brad Herring as New Chief Financial Officer

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, today announced the appointment of Brad Herring as Chief Financial Officer. “We are pleased to have Mr. Herring join Enfusion’s leadership team,” said Oleg Movchan, Interim Chief Executive Officer at Enfusion. “He brings a significant and successful track record as a public company CFO along with deep operational, control, complianc...
Back to Newsroom